Zdrowie i gospodarka · 09/09/2021

FDA Reopens Comment Period for ICH Q12 Guidance

The Food and Drug Administration (FDA) is extending the comment period for its draft guidance on implementing ICH Q12: Implementation Considerations for FDA-Regulated Products, originally published on May 20, 2021, to allow more time for public input.